Tomoyuki FUJII

Chairman

Chariperson's Opening Remarks

Tomonori Niwa

Bio-production Department, Pharmaceutical Division AGC Inc. Chiba Plant

Development and Manufacturing excellence in AGC Biologics Japan site-Providing New Value added CDMO service through Global Collaboration-

Shin Iida

Manager, Corporate Administration Department

Japanese Bio-CDMO Service by Cultivecs

Hideaki Nomura

General Manager, Bioprocess Dep., Life Science Div.

Life Science Business of JSR

Akira Kase

Introduction to Fujifilm Bio CDMO Business

Hideto CHONO, Ph.D.

General Manager Project Management

Takara Bio's CDMO service for cell and gene therapies

Teppei Kotake

Medical div. Business Management Dept. Medical Material Development Section

Role of CMOs for Oligonucleotide therapeutics and its prospect

Yun-Chi Lu

Universal Antibody Lock Enhance antibody drug disease selectivity and safety

On-target toxicities caused by systemic administration of antibody drugs limit their application. Here, we copied the hinge region as a universal antibody lock and pasted ...

Federico Pollano

Senior Vice President Business Development

Tailormade one-stop-shop solutions for development and production of biopharmaceuticals!

Jonathan Spaits / Kostlend Mara / Leon Tribolet

Project Development Analyst / Research Scientist

MicroRNA biomarkers, optimised cell lines, antiviral development

Drug development and therapeutic solutions from Europe

12 European companies, research organisations and clusters from 9 EU member states, which have been selected by the EU-Japan Centre for Industrial Cooperation, will present ...

Dr. Christian Kessler

Health Care

DIPEPTIDES IN CELL CULTURE - TOOLS FOR PERFORMANCE INCREASE AND RISK REDUCTION

Supplying mammalian cells with certain amino acids can be challenging. Some are chemically instable, like L-glutamine, others, like L-tyrosine, are barely soluble at neutral pH. ...

Mr. Anthony DeBoer

Clinical-Stage Technology for Best-in-Class Targeted Cancer Therapeutics

1. Clinical-stage antibody-drug conjugate (ADC) technology 2. Consistently delivers ADC assets with best-in-class efficacy and safety 3. Multiple partners developing Products with Synaffix technology (ADC Therapeutics, Mersana ...

Y-h. TAGUCHI

Professor of Physics Faculty of Science and Engineering

What ubivec aims for: AI drug discovery based on genomic and omics information

In recent years, the strategy of genome drug discovery or targeted drug discovery has attracted attention as a new drug discovery trend. However, because it ...

Luís Raiado, PhD

Business Development Manager

ViruSure - The CRO of Choice for BioSafety Testing

ViruSure GmbH is a leading CRO in the area of pathogen safety testing based in Vienna. We have a solid track record serving the Japanese ...

Junya Kobayashi

Research & Business Promotion Division Researcher

Dr. Nick Hutchinson

NEW APPROACHES TO DELIVERING CELL CULTURE BIOMANUFACTURING

Fujifilm Diosynth Biotechnologies set out to minimize the host of hazard pathways that can introduce schedule, quality, development, regulatory, and business risks to the supply ...

1) Severine Fagete 2) Thomas Jung

1) Director, CLD 2) Vice President, BD

Hidekazu Hiroaki

Professor

Protein-protein interaction inhibitor as a novel therapeutic agent for osteoporosis and barrier-related disease

Protein-protein interaction (PPI) is thought to be a target of drug discovery. PPI-inhibitors are potentially more specific and safer than molecular target drugs. Usually, discovery ...

Tsuyoshi Shuto

About approach of Kumamoto University Useful and Unique Natural Products for Drug Discovery and Development

Based on our Useful Natural Product (USP) Library, we establish cultivation systems that provide steady supplies of high quality USPs. We also establish an original ...

Yousuke Katsuda

Faculty of Advanced Science and Technology, Assistant Professor

Regulation of gene expression by Staple nucleic acid

We propose a system that makes it possible to construct artificial RNA G-quadruplex structures (RGq) using staple oligomers that can be approximated to guanine repeat ...

Akira Minami

School of Pharmaceutical Sciences, associate professor

Antidiabetic effect of the sialidase inhibitor 2,3-dehydro-2-deoxy-N-acetylneuraminic acid with a low risk of hypoglycemia

Sialidase cleaves a sialic acid residue from a sialylglycoconjugate. Histochemical imaging of the mouse pancreas using BTP3-Neu5Ac, a highly sensitive histochemical imaging probe for sialidase ...

Takuya Maeda

Department of Laboratory Medicine, Professor

Innovative rapid detection procedure of fluoroquinolone-resistant Neisseria gonorrhoeae

A rapid and easy-to-perform detection procedure for timely identification of pathogens and their drug susceptibility is essential for the proper use of antimicrobial agents and ...

Tanaka Toshio

Department of Systems Pharmacology Graduate School of Medicine professor

Patient-Derived Xenograft for Precision Medicine and Zebrafish-Based Drug Discovery

Zebrafish-based drug discovery develops internationally and is specified in the ICH guidelines in 2019. We have created a wide range of human disease models and ...

SATORU FUNAMOTO

Faculty of Life and Medical Science / Associate Professor

A novel anti-Alzheimer's disease therapeutic approach "APP-specific binding peptide to inhibit Abeta production"

Alzheimer's disease (AD) is the most common form of dementia related with amyloid beta (Ab) deposition in brain. Accumulative evidences support the notion that Ab ...

Toru Maekawa, Srivani Veeranarayanan, Mohamed Sheikh Mohamed,

Introduction to bio-nano science and technology carried out at the Bio-Nano Electronics Research Centre

Introduction to bio-nano science and technology carried out at the Bio-Nano Electronics Research Centre Toru Maekawa, Introduction to nano bio-imaging Srivani Veeranarayanan, Introduction to nano ...

Ikuo Fujii

Department of Biological Science, Professor

Post-antibody drugs: Generation of a novel class of drug modalities based on molecular-targeting helix-loop-helix (HLH) peptides.

Antibodies are indisputably the most successful reagents in molecular-targeting therapy. However, use of antibodies has been limited due to the biophysical properties and the cost ...

Takashi Inui

Graduate School of Life and Environmental Sciences, Professor

Development of cancer-targeting DDS with function of controlled drug release.

Drug delivery system is one of the latest medical technologies, and is a technology for delivering the required amount of drug to the target organ, ...

Kevin Pong

Translation Control Therapeutics Platform for the discovery of small molecule drugs that specifically control mRNA translation

Anima Biotech is advancing Translation Control Therapeutics, the first and only platform for the discovery of small molecule drugs that specifically control mRNA translation as ...

Yuko Kikuta

Project Officer, Economic Section

Key player in global life science and health industry

Small country though it is, the Netherlands is one of the major players in global life science and health industry. Nearly 2,900 life science companies ...

Simon Folkertsma

Healthy Living

Predictive and Personalized Health Technologies and Services in pre- and early clinical R&D at TNO

The Netherlands Organization for Applied Scientific Research (TNO) is an independent organization, active in Life Sciences and Health. TNO supports pharmaceutical companies in the area ...

Norimasa Morita

Business Development Director Asia

Accelerating early drug discovery using uHTS

Accelerating early drug discovery using uHTS

Ronald ten Berge

Chief Business Officer

Accelerating early drug discovery using uHTS

Yoko Ejiri

Organ-on-a-chip technology as a routine tool in drug discovery and development

Bart Scheerder

Director Biobank Knowledge and Expertise Center (BiKE)

The Dutch Microbiome Project; first clues to healthy gut microbiome and engraftment of probiotics

Lissa Boxy / Sandra de Wild-Chardonnens

Senior Account Manager LSH

What makes the Netherlands an attractive location for Japanese biopharma or medtech companies?

Mr Jean-Marc Juteau

Commissioner

Biotech cluster of Greater Montreal

The Biotech City is a biotechnology and life sciences hub of the Metropolitan Montreal including world renowned biopharmaceutical firms and research institutes employing more than ...

Mr. Gilbert Bernie

CEO

Alzheimer, Stem Cell, neurology

At STEMAXON, we aim to be the leader for drug development and disease modeling of sporadic Alzheimer' disease - the most prevalent dementia worldwide. This ...

Dr Shant Der Sarkissian

Co-founder & CEO

Optimization of cell therapy and transplantation

Targa Biomedical specializes in pharmacological treatments increasing the therapeutic impact of cell therapy, regenerative medicine and opportunities for organ transplantation. Also develops infarct-sparing molecules for ...

Economic and Commercial Office, Embassy of Spain

BIOTECHNOLOGY FROM SPAIN: NEW GLOBAL BUSINESS OPPORTUNITIES

Luigina Cirone

The Italian Biotech Industry

Nick Johnson

SVP, Business Development, Asia

INDiGO-Select. Managing the Discovery:Development Interface for Long Term Success

In order to reduce attrition of candidates throughout the development phase, quality but also cost and speed remain key drivers. Evotec's INDiGO platform delivers these ...

Hiroki Wada

Business Development

Enabling Success in Drug Discovery

Iife Science clusters and companies in Swden and Medicon Valley

Innovative life Science technologies in Sweden and Medicon Valley

Clusters and companies of Pharmaceutical, Medtech, HealthTech and Regenerative Medicine feild in Sweden and Medicon Valley.

Technology of Diagnosis and therapeutics for AD and LBD

Department of Pharmacology Professor

Technology of Diagnosis and therapeutics for AD and LBD

Alzheimer's dementia (AD) is caused by neuroinflammation and amyloid beta accumulation in the brain. Lewy body dementia (LBD) including Parkinson's disease dementia is caused by ...

Jared Hahn

Head of Business Development

Advancements in Transdermal Drug Delivery Using the PassPort® System

David Sokolowski

Global Product Manager, Continuous Clarification

Acoustic Wave Separation - A non-filtration approach for continuous clarification of perfusion cell culture

We report on a disruptive and scalable single-use technology for cell retention during perfusion cell culture based on an acoustophoretic separation. At the process development ...

Kosuke Minamihata

Highly productive protein expression system using silkworm

Silkworm-baculovirus protein expression system is capable of producing difficult-to-express proteins and also is suitable for protein production of many kinds with small quantity. For culturing ...

Hiroyuki Takeda

Rumi Naono

Faculty of Medicine, Anatomy, Assistant Professor

New pain treatment of human gene-derived peptides, and the role of orphan GPCR in itch mechanism

1) Pain is an unpleasant sensation that acts as a warning system. Our previous study suggests that human derived-peptide has suppressive effect of inflammation and ...

Naito Tadasuke

Katsuyoshi Matsunami

Professor, Department of Pharmacognosy, Graduate School of Biomedical and Health Sciences

Anti-Leishmania and anti-melanogenesis inhibitors from plant resources

Comprehensive analysis reveals that approximately 65% of therapeutic small-molecule drugs are related to natural products. Thus, natural resources including plants remain to be important sources ...

Takeshi Maruyama

Waseda Institute for Advanced Study Assistant Professor

Epithelial cell-cell communication to facilitate the aberrant cell elimination

So far, we have no effective strategies to defeat malignant cancers, and in many cases of pancreatic cancer, metastasis is found even in the early ...

Hoshi Masato

HIROAKI KITAGISHI

Faculty of Science and Engineering / Associate Professor

The chemical tools for removal and delivery of carbon monoxide that is a toxic but essential gas in the living organisms

Whereas carbon monoxide (CO) is well known as a toxic gas, CO is continuously produced in our body. CO works as a signal messenger in ...

Shunsuke Oishi

Institute of Transformative Bio-Molecules, Nagoya University

Gene-based Cyclic Peptide Library for Phenotypic Screenin

Phenotypic screening with chemical library is a powerful tool to find novel bioactive compounds. Many small molecules have been discovered by this approach, some of ...

Yoshiro CHUMAN

Niigata University Faculty of Science Department of Science , Associate Professor

Development of Ion-responsive DNA Aptamer (IRDAptamer) drugs targeting Intracellular Oncogenic Proteins

Antibody drug has been one of the major modalities of medical treatment for various cancers. In order to develop more safety drugs, spatiotemporally controlled drugs ...

Takeshi Wada

Professor, Department of Medical and Life Science, Faculty of Pharmaceutical Sciences

Masayuki Sakurai

Junior Associate Professor, Division of Molecular Pathology, Research Institute for Biomedical Science

Tomokatsu Ikawa

Professor, Division of Immunobiology, Research Institute for Biomedical Sciences

Eri Segi

Associate Professor, Department of Biological Science and Technology

Development of evaluation for antidepressant treatment focused on hippocampal responsiveness

Noriko Tamakoshi/Nobuo Tsukamoto

Initiatives for promoting research collaboration at Keio University and introduction of seeds

TAKASU, Masaki

Associate Professor, Faculty of Applied Biological Sciences

Translational research based on veterinary medicine

The more complex a study, the less one researcher can solely complete it. The research is likened to team sports, and the cooperation of players ...

Dr. Christian Kessler

Health Care

DIPEPTIDES IN CELL CULTURE - TOOLS FOR PERFORMANCE INCREASE AND RISK REDUCTION

Supplying mammalian cells with certain amino acids can be challenging. Some are chemically instable, like L-glutamine, others, like L-tyrosine, are barely soluble at neutral pH. ...

Dr. Ying-Shuan Lee

Bioactivity Identification, Institute of Pharmaceutics/Director

DCB, Your Best Innovation Partner

The Development Center for Biotechnology (DCB) was established as a nonprofit research institution in 1984 by Taiwan's Ministry of Economic Affairs and are focusing on ...

Toyotaka Sato

Screening of vivoEF inhibitors for site-specific therapy aginst bacterial infections

Antimicrobial resistance is plobrematic worldwide. However, the development of new antimicrobial agents continues to decrease. Particularly, compounds targeting new bacterial factors and efffective against multidrug ...

TORASHIMA Takashi

Director CTO

Human peripheral B-derived novel Bio-business

Comparison of mouse- or human-drived antibody is nonsense. Advantage of these mothod is completly different. In mouse case, it may easily generate antibodies by sensitization ...

Kiyoshi Takayama

CEO

Generation of anti-GPCR antibodies by an innovative high-throughput single-cell technology

We focus on generating therapeutic anti-GPCR antibodies by utilizing an original technology (MoGRAA® Discovery Engine) that has created many functional antibodies. Recently we have advanced ...

Ken-ichi MARUYAMA

CEO

Introduction of Navigation Drug

In cancer surgery, it is important to remove all the cancer cells, and visualization of micro cancers is required. As a new method, we are ...

Yuji Kogami

President & CEO

Macrocyclic peptide library development

Macrocyclic peptide drug discovery is attracting attention as a new modality. SkySea pharmaceutical Inc. started creation of a macrocyclic peptide library by utilizing the synthetic ...

Motoki Susa

President

Proposal to use our novel microfluidic device "iLiNP" and its next generation version for manufacturing of size-controlled lipid nanoparticles.

Our novel microfluidic device, named iLiNP (innovative Lipid Nanoparticle Production device) has a microfluidic channel with two-dimensional baffle mixer structure. We can easily and rapidly ...

Don Rindell

Managing Director, Camino International, LLC

Professional Support for US Market Entry 'What LSMIP can do for your Business'

Takeshi Omasa

Prof.

"Manufacturing Technology Association of Biologics(MAB)--From therapeutic antibody to cell and gene therapy"

The Manufacturing Technology Association of Biologics (MAB) developed integrated technology platforms for the biologics production. Technology Association is non-profit mutual benefit organization (cooperation) and this ...

Hiroshi Morioka

Faculty of Life Sciences (Pharmacy), Professor

A novel low molecular weight antibody aimed for practical use

Currently, many antibody drugs are used, and new antibody drugs are being developed. The target of antibody drug is limited extracellularly, so depletion of the ...

Ryusho Kariya

Joint Research Center for Human Retrovirus Infection, Specially Appointed Assistant Professor

Drug discovery research using humanized mouse

Severe immunodeficient mice are used as recipients for human cells or tissues. Sever immunodeficient mice is difficult to bleed and very expensive, therefore many researcher ...

Uemura Naoto

Atsushi Kaneda

Professor, Department of Molecular Oncology, Graduate School of Medicine

Development of region-selective middle-molecule epigenetic inhibitor

Cancer arises through accumulation of epigenetic and genetic alterations. The accumulated epigenomic aberrations can play causal roles in tumorigenesis, and therefore be druggable targets. Taking ...

Kadonosono Tetsuya

School of Life Science and Technology, Life Science and Technology Open Innovation Hub (LiHub)

Ito Akihiro

Novel functions of lysine long-chain acyl modifications found from drug discovery research and development to new drug discovery research

We previously showed that NAD+-dependent lysine deacetylase SIRT2 promotes cancer cell migration by regulating acetylation of cortactin important for cancer invasion. In this regard, we ...

Ryoji Siuno

Medical chemistry Lecturer

Structural biology of human GPCR for drug dioscovery

Since X-ray crystal structure analysis technology has been established,speeding up drug discovery by structure-based drug discovery based on structural information is expected. In recent years, ...

Koushi Hidaka

Division of Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences / Lecturer

A new technology that enables OFF to ON control of protease activity and its applications

In recent years, protein degradation inducers, associated with proteasome such as PROTAC and SNIPER targeting pathological proteins, are attracting most attention toward clinical application. These ...

Yoshimasa Tanaka

Development of an academic drug discovery system harnessing regional characteristics in Nagasaki Prefecture

Nagasaki University focuses on the development of therapeutic interventions for cancer, autoimmune diseases, infections and radiation-induced damage. We have established networks with many universities and ...

Takeshi Fuchigami

Graduate School of Biomedical Sciences, Nagasaki University, Associate Professor

Development of chromone derivatives as diagnostic agents for amyloid-related diseases

The chromone derivatives in the present invention have the following three properties: 1)high binding affinities to scrapie prion protein aggregate (PrPSc), 2)high blood-brain barrier permeability, and 3)rapid clearance ...

Tatsuo Ito

Assistant Professor, Department of Public Health, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan

Takanori Sasaki

Assistant Professor, Collaborative Research Center for Okayama Medical Innovation Center (OMIC), Okayama University

Molecular Imaging Researches at Okayama Medical Innovation Center (OMIC)

Okayama Medical Innovation Center (OMIC) promotes open innovation by offering supports in drug development-related discipline to fellow researchers. We focus on development of antibody drug ...

Matsui Takanori

Natsuka Kiyama, Ryo Takahashi

Clinical Innovation

Introduction of high-sensitive immunoassay system HI-1000 and recombinant protein production service ProCube

Sysmex Corporation will introduce HI-1000, full-automated high-sensitive immunoassay system for RUO, ProCube, recombinant protein production service. Key features of HI-1000 are full-automation, high sensitivity and flexibility. ...

NAKASHIMA Katsuhiko

Senior Researcher, Manufacturing Science and Technology, Regenerative Medicine Business Sector

Chikage Yamamoto

R&I Business Development

3D cell layering system S-PIKE technology

CYFUSE Corporation innovated "Micro Needle Array" technology (= Kenzan-Method) enabled 3D tissue fabrication with 100% cell only. CYFUSE's Bio-3D printer "S-PIKE" which equipped with only-one ...

hirofumi komatsubara

Introduction of the non-clinical safety study of regenerative medicine product and the infection study

Negishi Jun

Assistant Professor

Development of biomaterials and cell-containing materials for tissue regeneration

Currently, cell therapy for tissue regeneration has been performed, and tissue regeneration has been realized by transplanting single to several layers of cells on the ...

AKASHI Mitsuru Ph.D

Special professor

Layer-by-Layer Three-dimensional (LbL-3D) Tissues toward Drug Discovery Support and Regenerative Medicine

The fabrication of artificial three-dimensional (3D) tissues with similar function to native organ is a greatly challenge for implantable tissues in regenerative medicine, and for ...

Yukihito Ishizaka

Department of Intractable Diseases

A protein-based cell engineering system

Recent progress of regenerative medicine implies that a variety of cells can be engineered by ectopic expression or repression of transcriptional factors in somatic cells. ...

Toru Kawamura

Head, Director's Office

Industry-academia collaboration for medical applications of iPS cells and licensing the use iPS cells

The Center for iPS Cell Research and Application (CiRA) is conducting basic research, drug discovery, and regenerative medicine to realize medical applications of iPS cells. CiRA ...

Iwaguro Hideki

Director

Open Innovation of Regenerative Medicine at Private Clinic

Hiroki Danno

Co-CEO

Kobayashi Taro

Norihiko Hata

R&D Department, Director

Development of Cell Culture Apparatus with Regenerative Medical Technology

Sauro Vicini

Cluster Manager

REGENERATIVE MEDICINE INNOVATION HUB OF EMILIA-ROMAGNA

The Regenertive Medicine Innovation Hub of the Emilia Romagna Region is a combination of research centers with deep experience in development and industrialization of GMP ...

Yumi Matsuzaki

Director

Highly Purified MSC, REC and its clinical application

PuREC was established to provide highly purified mesenchymal stem cell (REC) for research and clinical use, based on the direct separation method to isolate mesenchymal ...

Komei Fukushima

CEO and President

K Pharma's Challenge

Our continued focus is on cell therapy for spinal cord injury, SCI, and brain infarction using neural progenitor cells from multi-potential iPS cells, iPSCs, and ...

Tamer Mohamed

CEO

3D Bioprinting for Regenerative Medicine

Aspect Biosystems is a Canadian biotechnology company operating at the leading edge of 3D printing and regenerative medicine. Our proprietary microfluidic 3D bioprinting platform is ...

New software features for environmental monitoring in the process of regenerative medicine

RION will introduce effective airborne particle counter in the process of regenerative medicine. Our monitoring system integrates not only cleanliness, and also temperature, humidity, differential ...

Toshiyuki Nakayama

President

CDMO Services and Facility Introduction of Nikon CeLL innovation Co., Ltd.

ikon CeLL innovation Co. Ltd.(NCLi) announced an exclusive collaboration in 2015 with Lonza, a leader in pharmaceutical and biotech contract manufacturing, in order to establish ...

Hardy TS Kagimoto

Chairman and CEO

Healios Thought on Regenerative Medicine In The Future

In order to quickly deliver new treatments to as many patients as possible, we are aiming for further expansion of our business based on both ...

Nobuyuki Kawagoe

Meiseki Hidenori

Business Development, Cell and Gene Technologies

GMP Production for Cell and Gene Therapies and Challenges to Industrialization

Cell and Gene Therapy industry face challenges that are unique to their products and indication. In this Lonza session, we will discuss anticipated challenges to ...

Oishi Tatsuya

Prof. dr. Willem E. Fibbe & dr. Janny van den Eijnden

Creating impact from science with regenerative medicine and Organ-on-Chip technology proposition of Leiden University Medical Center (the Netherlands)

Yoshikazu Kato

Masazumi Fujiwara

Graduate School of Science, Lecturer

Realtime temperature measurement of single cells with high precision

Body temperature monitoring is one of the first bio-analyzing methods in our daily lives. It is however very challenging to measure the temperature inside cells ...

Yukawa Hiroshi

iPS cells imaging by quantum nano-optics for regenerative medicine

Mikihito Kajiya

Assistant Professor, Department of Periodontal Medicine, Graduate School of Biomedical and Health Sciences

Development of genuine bone-like tissue from clumps of MSCs/ECM complexes for craniofacial bone regenerative therapy

A number of patients who lost their maxillofacial bones due to infections, cancers, and traumas are suffering from mastication disorder, dysarthria, and cosmetic disturbance. Autologous ...

Shogo Takashiba

Professor, Department of Pathophysiology-Periodontal Science, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University

Development of periodontal regeneration therapy for horizontal alveolar bone resorption using collagen-binding basic fibroblast growth factor

Periodontitis is an inflammatory disease that causes destruction of periodontal tissues. To treat the destroyed periodontal tissues, basic fibroblast growth factor (bFGF) has been utilized ...

Kobayashi Toyoshige

Luc St-Onge, Ph.D.,

Head of Business Development and Licensing,

Setsuko Hashimoto, Ph.D.

President and CEO

Toward the Global Commercialization of Cell Sheet Regenerative Medicine

Yutaka / Yanagita, Ikuo / Kawauchi

International standardization in the field of regenerative medicine - toward achievement of "innovation"

Regenerative medicine has the following characteristics: 1) translation of cutting-edge science and technology; 2) formation of value chain consisting of a variety of industries; 3) ...

Dr. Claus Schaffrath, MD MSc

Managing Director

Product Claim Management for Medical Devices: How to create value under the new European Medical Device Regulation?

The European Medical Device market is changing. The new Medical Device Regulation (MDR) will come into force by May 2020. It asks for better evidence ...

Etsuro Ito

Professor

Easy, rapid, ultrasensitive kit for measuring proteins and nucleic acids in early diagnosis and its measuring apparatus

Generally, PCR is thought to be a definitive diagnosis, but it cannot discriminate between live and dead bacteria. Thus, an ideal diagnosis needs to detect ...

Takuya CHIBA

Faculty of Human Sciences Professor

Evaluation and identification of calorie restriction mimetic molecules

In this study, we tried to develop a system to assess pro-longevity status in cells and mice. We previously identified genes up-regulated in the liver ...

Enoch Y Park

Research Institute of Green Science and Technology / Professor

Development of electrical pulse-induced electrochemical biosensor for a highly sensitive and rapid hepatitis E virus detection

Hepatitis E virus (HEV) is a zoonotic food-borne infection that belongs to the fourth-class infection of the infectious diseases law, and causes of acute viral ...

Dr. Claus Schaffrath, MD MSc

Managing Director

Product Claim Management for Medical Devices: How to create value under the new European Medical Device Regulation?

The European Medical Device market is changing. The new Medical Device Regulation (MDR) will come into force by May 2020. It asks for better evidence ...

Giovanni Stracquadaneo

Business Development Manager

Genomeup, A.I. for precision medicine in genetic rare diseases.

GenomeUp is an AI platform (SaaS) to enabling doctors and clinical institutions to diagnose and treat rare genetic diseases in less than 24h. The Whole ...

Kazutaka Hirakawa

Graduate School of Integrated Science and Technology Department of Engineering / Professor

Cancer-selective agents for photodynamic therapy

Inoperative cancer patients have been increasing in Japan, due to the difficulty in hemostasis. Therefore, a less-invasive treatment is strongly required, however, well-known treatment, for ...

Tanaka Toshiaki

School of Life Science and Technology, Life Science and Technology Open Innovation Hub (LiHub)

Visualization of processing and secretion of type I collagen by live imaging

Shinji HASHIMOTO

Director, Research & Development Department

Opening remarks

The recent rapid changes in the external environment surrounding pharmaceuticals and changes in the internal business conditions are creating significant changes in the pharmaceutical industry. ...

Masaru OSTUKA

Head of Takeda Digital Accelerator Japan Digital Unit

Beyond the Pill-Digital Health Strategy for Pharmaceutical Manufacturers- Overview

Ryo SHIMIZU

Head of Digital Transformation

Diabetes Care App TOMOCO-Mitsubishi Tanabe Pharma's Digital Medicine, First stage-

Akira OOGURO, Shinya SOGAME

Business Producer, Strategic Innovation Office, Marketing & Innovation

Beyond the Pill approach aiming for zero fragility fractures.

Tianhua CHI

Junior Digital Alliance Manager, Open Innovation Center Japan

Bayer's Digital Innovation

Motohiro KANAYAMA

Business producer, Rx+ Business Accelerator

Efforts to create business by fusing different fields

Takehiko NOMURA

Senior Director, Frontier Business Office

Contribute to"wide-ranging well-being" together with pharmaceutical products

Hayashi Nobuhiro

School of Life Science and Technology, Life Science and Technology Open Innovation Hub (LiHub)

Kiyotaka HARA

Graduate School of Nutritional and Environmental Sciences, Associate Professor

Development of Energetic Cell Factory

A problem of microbial production is decrease in the cell growth and production rate due to its intracellular energy shortage. We aim to accelerate the ...

Masahiro SAMEJIMA

Project Professor, Faculty of Engineering

Opening Remarks: Realizing the bioeconomy -biotech policy and forefront technologies-

The JBA Green Bio-innovation Forum (GIF) aims to build a sustainable society by activating green biotechnology and industry. With the goal of realizing the world's ...

Sachiko MORI

TBD

Tadashi HATTORI

TBD

Akira SASAKI

Deputy Director, Bio-Industry Division, Commerce and Service Industry Policy Group,

Recent measures contributing to Bioeconomy

Yoshihiro HAYAKAWA

Senior Manager, Analytical & Instruments Division Global Application Development Center

Development of high throughput and high precision metabolome analysis technology to accelerate smart cell development

Takeshi KUBOTA

Senior Researcher, Molecular Microbiology and Biotechnology Group

Development of biorefinery production technology to attain a sustainable society

To realize the emerging concept "Bioeconomy", global effort to build a low-carbon society/a sustainable society has been devoted. In this context, RITE has developed an ...

Arimitsu USUKI

Specially appointed professor, Lab. of Active Bio-based Materials, Research Institute for Sustainable Humanosphere

Overview and Progress of the NCV(Nano Cellulose Vehicle) Project

Cellulose nano fiber (CNF) is a new class of bio-based materials with characteristics such as high strength, low thermal expansion, low density, and is produced ...

Shigeru DEGUCHI

Yasuhiro SAKAI, M.D., Ph.D.

Ryoichi Kusama

Co founder & COO

The Prospect of Virtual Clinical Trials in Japan ~the utilization of Artificial Intelligence in analyzing various, long-term collected patient data as the result of digitization~

Virtual clinical trials have been attracting attention as the next generation clinical trials in which patient data can be accumulated remotely with digital tools. In ...

Teppei Konishi

Observation of stained cell image by using artificial intelligence and development of cytologist supporting system

Since inadequate numbers of specialists of the stained cell image observation, like pathologists or cytologists, are one of the problems in medical field, developments of ...

Atsushi FUJIMOTO

Niigata University University Medical and Dental Hospital Dermatology , Lecturer

Application of deep learning for early diagnosis of severe drug-induced skin reactions

Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are rare, life-threatening mucocutaneous reactions, most commonly triggered by medications, showing severe and extensive skin detachment. The ...

Liusong Yin

Antibody Drug Discovery Dept.

Design and Development of Innovative Antibody Drugs

GenScript's innovative platform for SMAB bsAb and mAb discovery provides strong solutions for biologics development.

Tamio Mizukami

President, CEO

Innovations in drug discovery and regenerative medicine developed by "cell visualization" technology

The "cell visualization" technology is a new technology that can predict cell characteristics such as cell life and death from bright field cell images. In ...

Shigeo Arai

Associate Professor

The world of cell structures spreading by electron microscopy

Nagoya University supports a molecular biologic study by a high voltage electron microscopy (HVEM) and excellent electron microscopes. These microscopes are very used by many ...

Yasuhiko Taira

Professor

Light irradiation as a novel treatment for carbon monoxide poisoning

An estimated 58,000 emergency cases of carbon monoxide (CO) poisoning occur yearly in Japan. The treatment modalities for CO poisoning, especially normobaric oxygen and hyperbaric ...

Hiroyuki Kimura

Shigehiro Yoshimura

Dr. Jasper van Weerd

Lipid based bio-mimetic coating with anti-fouling properties

Mrs Suzie Talbot

President

Clinical research of phase I to IV trials

DIEX's unique platform allows the investigator to take control of the study project without having to worry about administrative procedures.Our business development team acquires research ...

Mr. Frédéric Leduc

President

Humanized chicken antibody discovery in oncology

We are an innovative biotechnology company specializing in the discovery and engineering of humanized chicken antibodies for targets with recognized, but unexploited, therapeutic and diagnostic ...

Motoki Takagi, Ph.D.

Ken-ichi Kusumoto

CEO

Introduction of GMEP products and custom services for mammalian cell culture in research and development of biopharmaceuticals.

Since 1999, we have consistently pursued on serum-free culture for mammalian cells. And our GMEP succeeded in the development of chemically defined medium for HEK293 ...

Izuho Hatada

Institute for Molecular and Cellular Regulation/Professor

Rapid generation of conditional knockout mouse

Conditional knockout mouse are usually used for disease model animal because more than 60% of knockout mouse strains show a prenatal lethality. The conventional method ...

Masaki Shintani

Graduate School of Integrated Science and Technology Department of Engineering / Associate Professor

Development of new bacterial broad host range plasmids

Novel self-transmissible plasmids were exogenously captured from environmental samples. A total of 272 recipients were successfully obtained as plasmid host candidates. The whole nucleotide sequences ...

Masafumi Jinno

Professor

HIRONOBU MINAI

Section Manager Sapporo Research Development Office

Norikazu Maruyama

Development of Simplified Motion Analyzing System Employing a Function of a Smartphone

In the field of rehabilitation medicine and sports science, the analysis of human movement often affords the key to the decision on what treatment or ...

Takayuki Shibata

Graduate School of Health Sciences/Associate Professor

A novel fluorescence dye that emits light in a certain pH region

In this study, a novel fluorescent dye emitting light in a certain pH region has been developed. The dye fluoresced under weakly acidic condition, and ...

Hideki Yamamoto

Assistant Professor, Department of Clinical Genetic Medicine, Okayama University Hospital

Okayama University Hospital Biobank (Okadai Biobak): New Challenges Facing at The Cancer Genomic Era

Okayama University Hospital Biobank (Okadai Biobank) is offering various types of human sample such as blood, urine, and tissues with the detailed clinical information since ...

Katsuya Hirai

Biomedical Division Life Science Solution Development Department

Cell culture solution provided by PHC

Masahiro Kanaoka

Division of Biological Science, Graduate School of Science, Nagoya Univerisy

Development of in vitro fertilization system in plants

Successful fertilization relies on precise interaction of male and female reproductive cells in plants. Sperm cells, the male gametes, are carried by pollen tube through ...

Mr. Jean-Philippe Couture

Application specialist

Multi-omics mass spectrometry services

PhenoSwitch Bioscience is a Canadian contract research organisation that offers spectrometry services to biotechnology, pharmaceutical and academic research groups. We want to collaborate with actors ...

Shinya Otsuji

Manager

Mitsuyo Ohmura

R&D seeds discovery and industry-academia collaboration at MARC

In order to accelerate the development of medical seeds from academia and deliver innovative medicine/medical devises in clinical practice, we established "Metropolitan Academic Research Consortium" ...

Kondoh Shinji

Regenerative Medicine Promotion Office General Manager

Introduction of regenerative medicine business in EPS

In the development of regenerative medicine products, collaborating with experienced and highly specialized CRO(Contract Research Organization) is a very important factor. Since its establishment in ...

Yoshiharu Ichiki

Bio Project Division Director

Introduction of Fukuoka BioValley Project

Kento MINAMINO

Patent Attorney

Current patent status of basic structure of Chimeric Antigen Receptor (CAR)

In March 2019, Japan authorities approved Kymriah, that is a drug of a new modality called CAR-T cells. Although the drug price of Kymriah is ...

TAKASHI SANO

Aizawa Yasunori

School of Life Science and Technology, Life Science and Technology Open Innovation Hub (LiHub)

Sohei Fukuyama

Claudio Mazzucchelli, Head, Swiss Business Hub Japan, Embassy of Switzerland in Japan Toshihiro Matsuda, Head, Swiss Business Hub Japan-Investment Promotion, Embassy of Switzerland in Japan

Open Innovation in Switzerland

Tomoyoshi Koyanagi, Naofumi Makino

Tsukuba Clinical Research & Development Organization Professor, Head of Translational Research Promotion and Education Center(Koyanagi), Chief Director of JETRO Kyoto(Makino)

Creating healthcare startups from Kyoto: Introduction of Healthcare Venture Conference(HVC)

The Healthcare Venture Conference (HVC) Kyoto is an annual pitch event for healthcare startups in English since 2017. The size of the event have grown ...

Takashi Sera

Professor, Graduate School of Interdisciplinary Science and Engineering in Health Systems, Okayama University

Application of artificial nucleic acid binding proteins to medical treatment and agriculture

Based on recognition patterns found in natural nucleic acid-binding proteins and possible base-amino acid interactions, we have developed a recognition code table. Based on this ...